Vital Therapies (VTL) P/E Ratio
P/E Ratio as of Dec 4, 2025: -0.80
Average-0.8062
Median-0.8000
Minimum-0.9000
Maximum-0.7200
-0.80
0.09 (12.68%)past month
The P/E ratio for Vital Therapies (VTL) is -0.80 as of Dec 4, 2025. This represents a decrease of -8.05% compared to its 12-month average P/E ratio of -0.87. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Vital Therapies P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Vital Therapies’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Vital Therapies to industry peers.
Vital Therapies P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Vital Therapies’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Vital Therapies to industry peers.
Vital Therapies (VTL) P/E Ratio Insights
See Vital Therapies’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Vital Therapies (VTL)
Order type
Buy in
Order amount
Est. shares
0 shares
Vital Therapies (VTL) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Dec 1, 2025 | $0.679 | -0.78 |
| Nov 3, 2025 | $0.7481 | -0.77 |
| Oct 1, 2025 | $0.96 | -0.99 |
| Sep 2, 2025 | $0.799 | -0.82 |
| Aug 1, 2025 | $0.9315 | -0.95 |
| Jul 1, 2025 | $0.6904 | -0.70 |
| Jun 2, 2025 | $0.70 | -0.71 |
| May 1, 2025 | $1.17 | -1.13 |
| Apr 1, 2025 | $1.065 | -1.03 |
| Mar 3, 2025 | $1.16 | -0.94 |
| Feb 3, 2025 | $0.9654 | -0.78 |
| Jan 2, 2025 | $1.02 | -0.82 |
Vital Therapies (VTL) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.80 | -1.23% |
| 2024 | -0.81 | +76.09% |
| 2023 | -0.46 | -2.13% |
| 2022 | -0.47 | -80.25% |
| 2021 | -2.38 | -54.49% |
| 2020 | -5.23 | — |
FAQs About Vital Therapies (VTL) P/E ratio
The latest P/E ratio of Vital Therapies (VTL) is -0.80, as of Dec 4, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Vital Therapies’s last 12-month average P/E ratio is -0.87, compared to its current P/E ratio of -0.80. This reflects a decrease of -8.05%.
Vital Therapies’s current P/E ratio of -0.80 is lower than its last 12-month average P/E of -0.87. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Vital Therapies’s average P/E ratio over the last 3 years is -0.72. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Vital Therapies’s average P/E ratio over the last 5 years is -1.56. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.